Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals

Identifieur interne : 000585 ( Istex/Corpus ); précédent : 000584; suivant : 000586

Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals

Auteurs : Anurag Rathore ; Animesh Chatterjee ; P. Sivarama ; Naohiko Yamamoto ; Tapan N. Dhole

Source :

RBID : ISTEX:9F928F739F1DB91A3396D803975A9B39B2F90D7A

English descriptors

Abstract

Abstract: Despite multiple sexual exposures to HIV-1 virus, some individuals remain HIV-1 seronegative. Although several genetic factors have been related to HIV-1 resistance, the homozygosity for a mutation in CCR5 gene (the 32-bp deletion, i.e., CCR5-Delta32 allele) is presently considered the most relevant one. The C-type lectins, DC-SIGN (present on dendritic cells and macrophages) and DC-SIGNR (present on endothelial cells in liver and lymph nodes) efficiently bind and transmit HIV-1 to susceptible cell in trans, thereby augmenting the infection. A potential association of the DC-SIGN and DC-SIGNR neck domain repeat polymorphism and risk of HIV-1 infection is currently under debate. To determine the influence of host genetic factors on HIV-1 resistance, we conducted genetic risk association study in HIV-1-exposed seronegative (n = 47) individuals, HIV-1 seronegative (n = 262) healthy control, and HIV-1-infected seropositive patients (n = 168) for polymorphism in neck domain of DC-SIGN and DC-SIGNR genes. The DC-SIGN and DC-SIGNR genotypes were identified by polymerase chain reaction method in DNA extracted from peripheral blood and confirmed by sequencing. Fisher exact or χ 2 test was used for static analysis. DC-SIGN genotype and allele distribution was fairly similar in HIV-1-exposed seronegative, HIV-1 seropositive, and HIV-1 seronegative control. There was no statistical significance in the differences in the distribution of DC-SIGN genotypes. A total of 13 genotypes were found in DC-SIGNR neck repeat region polymorphism. Among all the genotypes, only 5/5 homozygous showed significant reduced risk of HIV-1 infection in HIV-1-exposed seronegative individuals (p = 0.009). A unique genotype 8/5 heterozygous was also found in HIV-1 seropositive individual, which is not reported elsewhere.

Url:
DOI: 10.1007/s10875-007-9131-x

Links to Exploration step

ISTEX:9F928F739F1DB91A3396D803975A9B39B2F90D7A

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals</title>
<author>
<name sortKey="Rathore, Anurag" sort="Rathore, Anurag" uniqKey="Rathore A" first="Anurag" last="Rathore">Anurag Rathore</name>
<affiliation>
<mods:affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chatterjee, Animesh" sort="Chatterjee, Animesh" uniqKey="Chatterjee A" first="Animesh" last="Chatterjee">Animesh Chatterjee</name>
<affiliation>
<mods:affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sivarama, P" sort="Sivarama, P" uniqKey="Sivarama P" first="P." last="Sivarama">P. Sivarama</name>
<affiliation>
<mods:affiliation>AIDS Counseling and Treatment Center, Belgaum, India</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yamamoto, Naohiko" sort="Yamamoto, Naohiko" uniqKey="Yamamoto N" first="Naohiko" last="Yamamoto">Naohiko Yamamoto</name>
<affiliation>
<mods:affiliation>Department of International Health, Nagoya University School of Medicine, Nagoya, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dhole, Tapan N" sort="Dhole, Tapan N" uniqKey="Dhole T" first="Tapan N." last="Dhole">Tapan N. Dhole</name>
<affiliation>
<mods:affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: tndhole@hotmail.com</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9F928F739F1DB91A3396D803975A9B39B2F90D7A</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1007/s10875-007-9131-x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-M6TN1N0C-H/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000585</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000585</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals</title>
<author>
<name sortKey="Rathore, Anurag" sort="Rathore, Anurag" uniqKey="Rathore A" first="Anurag" last="Rathore">Anurag Rathore</name>
<affiliation>
<mods:affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chatterjee, Animesh" sort="Chatterjee, Animesh" uniqKey="Chatterjee A" first="Animesh" last="Chatterjee">Animesh Chatterjee</name>
<affiliation>
<mods:affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sivarama, P" sort="Sivarama, P" uniqKey="Sivarama P" first="P." last="Sivarama">P. Sivarama</name>
<affiliation>
<mods:affiliation>AIDS Counseling and Treatment Center, Belgaum, India</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yamamoto, Naohiko" sort="Yamamoto, Naohiko" uniqKey="Yamamoto N" first="Naohiko" last="Yamamoto">Naohiko Yamamoto</name>
<affiliation>
<mods:affiliation>Department of International Health, Nagoya University School of Medicine, Nagoya, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dhole, Tapan N" sort="Dhole, Tapan N" uniqKey="Dhole T" first="Tapan N." last="Dhole">Tapan N. Dhole</name>
<affiliation>
<mods:affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: tndhole@hotmail.com</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Clinical Immunology</title>
<title level="j" type="abbrev">J Clin Immunol</title>
<idno type="ISSN">0271-9142</idno>
<idno type="eISSN">1573-2592</idno>
<imprint>
<publisher>Springer US; http://www.springer-ny.com</publisher>
<pubPlace>Boston</pubPlace>
<date type="published" when="2008-01-01">2008-01-01</date>
<biblScope unit="volume">28</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="50">50</biblScope>
<biblScope unit="page" to="57">57</biblScope>
</imprint>
<idno type="ISSN">0271-9142</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0271-9142</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>DC-SIGN</term>
<term>DC-SIGNR</term>
<term>HIV-1</term>
<term>gene polymorphism</term>
<term>genetic association</term>
<term>tandem repeats</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Despite multiple sexual exposures to HIV-1 virus, some individuals remain HIV-1 seronegative. Although several genetic factors have been related to HIV-1 resistance, the homozygosity for a mutation in CCR5 gene (the 32-bp deletion, i.e., CCR5-Delta32 allele) is presently considered the most relevant one. The C-type lectins, DC-SIGN (present on dendritic cells and macrophages) and DC-SIGNR (present on endothelial cells in liver and lymph nodes) efficiently bind and transmit HIV-1 to susceptible cell in trans, thereby augmenting the infection. A potential association of the DC-SIGN and DC-SIGNR neck domain repeat polymorphism and risk of HIV-1 infection is currently under debate. To determine the influence of host genetic factors on HIV-1 resistance, we conducted genetic risk association study in HIV-1-exposed seronegative (n = 47) individuals, HIV-1 seronegative (n = 262) healthy control, and HIV-1-infected seropositive patients (n = 168) for polymorphism in neck domain of DC-SIGN and DC-SIGNR genes. The DC-SIGN and DC-SIGNR genotypes were identified by polymerase chain reaction method in DNA extracted from peripheral blood and confirmed by sequencing. Fisher exact or χ 2 test was used for static analysis. DC-SIGN genotype and allele distribution was fairly similar in HIV-1-exposed seronegative, HIV-1 seropositive, and HIV-1 seronegative control. There was no statistical significance in the differences in the distribution of DC-SIGN genotypes. A total of 13 genotypes were found in DC-SIGNR neck repeat region polymorphism. Among all the genotypes, only 5/5 homozygous showed significant reduced risk of HIV-1 infection in HIV-1-exposed seronegative individuals (p = 0.009). A unique genotype 8/5 heterozygous was also found in HIV-1 seropositive individual, which is not reported elsewhere.</div>
</front>
</TEI>
<istex>
<corpusName>springer-journals</corpusName>
<author>
<json:item>
<name>Anurag Rathore</name>
<affiliations>
<json:string>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</json:string>
</affiliations>
</json:item>
<json:item>
<name>Animesh Chatterjee</name>
<affiliations>
<json:string>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</json:string>
</affiliations>
</json:item>
<json:item>
<name>P. Sivarama</name>
<affiliations>
<json:string>AIDS Counseling and Treatment Center, Belgaum, India</json:string>
</affiliations>
</json:item>
<json:item>
<name>Naohiko Yamamoto</name>
<affiliations>
<json:string>Department of International Health, Nagoya University School of Medicine, Nagoya, Japan</json:string>
</affiliations>
</json:item>
<json:item>
<name>Tapan N. Dhole</name>
<affiliations>
<json:string>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</json:string>
<json:string>E-mail: tndhole@hotmail.com</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>DC-SIGN</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>DC-SIGNR</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>HIV-1</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tandem repeats</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>genetic association</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>gene polymorphism</value>
</json:item>
</subject>
<articleId>
<json:string>9131</json:string>
<json:string>s10875-007-9131-x</json:string>
</articleId>
<arkIstex>ark:/67375/VQC-M6TN1N0C-H</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>OriginalPaper</json:string>
</originalGenre>
<abstract>Abstract: Despite multiple sexual exposures to HIV-1 virus, some individuals remain HIV-1 seronegative. Although several genetic factors have been related to HIV-1 resistance, the homozygosity for a mutation in CCR5 gene (the 32-bp deletion, i.e., CCR5-Delta32 allele) is presently considered the most relevant one. The C-type lectins, DC-SIGN (present on dendritic cells and macrophages) and DC-SIGNR (present on endothelial cells in liver and lymph nodes) efficiently bind and transmit HIV-1 to susceptible cell in trans, thereby augmenting the infection. A potential association of the DC-SIGN and DC-SIGNR neck domain repeat polymorphism and risk of HIV-1 infection is currently under debate. To determine the influence of host genetic factors on HIV-1 resistance, we conducted genetic risk association study in HIV-1-exposed seronegative (n = 47) individuals, HIV-1 seronegative (n = 262) healthy control, and HIV-1-infected seropositive patients (n = 168) for polymorphism in neck domain of DC-SIGN and DC-SIGNR genes. The DC-SIGN and DC-SIGNR genotypes were identified by polymerase chain reaction method in DNA extracted from peripheral blood and confirmed by sequencing. Fisher exact or χ 2 test was used for static analysis. DC-SIGN genotype and allele distribution was fairly similar in HIV-1-exposed seronegative, HIV-1 seropositive, and HIV-1 seronegative control. There was no statistical significance in the differences in the distribution of DC-SIGN genotypes. A total of 13 genotypes were found in DC-SIGNR neck repeat region polymorphism. Among all the genotypes, only 5/5 homozygous showed significant reduced risk of HIV-1 infection in HIV-1-exposed seronegative individuals (p = 0.009). A unique genotype 8/5 heterozygous was also found in HIV-1 seropositive individual, which is not reported elsewhere.</abstract>
<qualityIndicators>
<score>9.06</score>
<pdfWordCount>4060</pdfWordCount>
<pdfCharCount>27082</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>8</pdfPageCount>
<pdfPageSize>595.276 x 790.866 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractWordCount>255</abstractWordCount>
<abstractCharCount>1824</abstractCharCount>
<keywordCount>6</keywordCount>
</qualityIndicators>
<title>Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals</title>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<title>Journal of Clinical Immunology</title>
<language>
<json:string>unknown</json:string>
</language>
<publicationDate>2008</publicationDate>
<copyrightDate>2008</copyrightDate>
<issn>
<json:string>0271-9142</json:string>
</issn>
<eissn>
<json:string>1573-2592</json:string>
</eissn>
<journalId>
<json:string>10875</json:string>
</journalId>
<volume>28</volume>
<issue>1</issue>
<pages>
<first>50</first>
<last>57</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Medical Microbiology</value>
</json:item>
<json:item>
<value>Internal Medicine</value>
</json:item>
<json:item>
<value>Infectious Diseases</value>
</json:item>
<json:item>
<value>Immunology</value>
</json:item>
</subject>
</host>
<ark>
<json:string>ark:/67375/VQC-M6TN1N0C-H</json:string>
</ark>
<publicationDate>2008</publicationDate>
<copyrightDate>2007</copyrightDate>
<doi>
<json:string>10.1007/s10875-007-9131-x</json:string>
</doi>
<id>9F928F739F1DB91A3396D803975A9B39B2F90D7A</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-M6TN1N0C-H/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-M6TN1N0C-H/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/VQC-M6TN1N0C-H/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher scheme="https://scientific-publisher.data.istex.fr">Springer US; http://www.springer-ny.com</publisher>
<pubPlace>Boston</pubPlace>
<availability>
<licence>
<p>Springer Science+Business Media, LLC, 2007</p>
</licence>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</p>
</availability>
<date>2007-06-16</date>
</publicationStmt>
<notesStmt>
<note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals</title>
<author xml:id="author-0000">
<persName>
<forename type="first">Anurag</forename>
<surname>Rathore</surname>
</persName>
<affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">Animesh</forename>
<surname>Chatterjee</surname>
</persName>
<affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">P.</forename>
<surname>Sivarama</surname>
</persName>
<affiliation>AIDS Counseling and Treatment Center, Belgaum, India</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">Naohiko</forename>
<surname>Yamamoto</surname>
</persName>
<affiliation>Department of International Health, Nagoya University School of Medicine, Nagoya, Japan</affiliation>
</author>
<author xml:id="author-0004" corresp="yes">
<persName>
<forename type="first">Tapan</forename>
<surname>Dhole</surname>
</persName>
<email>tndhole@hotmail.com</email>
<affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</affiliation>
</author>
<idno type="istex">9F928F739F1DB91A3396D803975A9B39B2F90D7A</idno>
<idno type="ark">ark:/67375/VQC-M6TN1N0C-H</idno>
<idno type="DOI">10.1007/s10875-007-9131-x</idno>
<idno type="article-id">9131</idno>
<idno type="article-id">s10875-007-9131-x</idno>
</analytic>
<monogr>
<title level="j">Journal of Clinical Immunology</title>
<title level="j" type="abbrev">J Clin Immunol</title>
<idno type="pISSN">0271-9142</idno>
<idno type="eISSN">1573-2592</idno>
<idno type="journal-ID">true</idno>
<idno type="issue-article-count">16</idno>
<idno type="volume-issue-count">6</idno>
<imprint>
<publisher>Springer US; http://www.springer-ny.com</publisher>
<pubPlace>Boston</pubPlace>
<date type="published" when="2008-01-01"></date>
<biblScope unit="volume">28</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="50">50</biblScope>
<biblScope unit="page" to="57">57</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2007-06-16</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Abstract: Despite multiple sexual exposures to HIV-1 virus, some individuals remain HIV-1 seronegative. Although several genetic factors have been related to HIV-1 resistance, the homozygosity for a mutation in CCR5 gene (the 32-bp deletion, i.e., CCR5-Delta32 allele) is presently considered the most relevant one. The C-type lectins, DC-SIGN (present on dendritic cells and macrophages) and DC-SIGNR (present on endothelial cells in liver and lymph nodes) efficiently bind and transmit HIV-1 to susceptible cell in trans, thereby augmenting the infection. A potential association of the DC-SIGN and DC-SIGNR neck domain repeat polymorphism and risk of HIV-1 infection is currently under debate. To determine the influence of host genetic factors on HIV-1 resistance, we conducted genetic risk association study in HIV-1-exposed seronegative (n = 47) individuals, HIV-1 seronegative (n = 262) healthy control, and HIV-1-infected seropositive patients (n = 168) for polymorphism in neck domain of DC-SIGN and DC-SIGNR genes. The DC-SIGN and DC-SIGNR genotypes were identified by polymerase chain reaction method in DNA extracted from peripheral blood and confirmed by sequencing. Fisher exact or χ 2 test was used for static analysis. DC-SIGN genotype and allele distribution was fairly similar in HIV-1-exposed seronegative, HIV-1 seropositive, and HIV-1 seronegative control. There was no statistical significance in the differences in the distribution of DC-SIGN genotypes. A total of 13 genotypes were found in DC-SIGNR neck repeat region polymorphism. Among all the genotypes, only 5/5 homozygous showed significant reduced risk of HIV-1 infection in HIV-1-exposed seronegative individuals (p = 0.009). A unique genotype 8/5 heterozygous was also found in HIV-1 seropositive individual, which is not reported elsewhere.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>DC-SIGN</term>
</item>
<item>
<term>DC-SIGNR</term>
</item>
<item>
<term>HIV-1</term>
</item>
<item>
<term>tandem repeats</term>
</item>
<item>
<term>genetic association</term>
</item>
<item>
<term>gene polymorphism</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>Biomedicine</head>
<item>
<term>Medical Microbiology</term>
</item>
<item>
<term>Internal Medicine</term>
</item>
<item>
<term>Infectious Diseases</term>
</item>
<item>
<term>Immunology</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2007-06-16">Created</change>
<change when="2008-01-01">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-M6TN1N0C-H/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="corpus springer-journals not found" wicri:toSee="no header">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType>
<istex:document>
<Publisher>
<PublisherInfo>
<PublisherName>Springer US</PublisherName>
<PublisherLocation>Boston</PublisherLocation>
<PublisherURL>http://www.springer-ny.com</PublisherURL>
</PublisherInfo>
<Journal OutputMedium="All">
<JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
<JournalID>10875</JournalID>
<JournalPrintISSN>0271-9142</JournalPrintISSN>
<JournalElectronicISSN>1573-2592</JournalElectronicISSN>
<JournalTitle>Journal of Clinical Immunology</JournalTitle>
<JournalAbbreviatedTitle>J Clin Immunol</JournalAbbreviatedTitle>
<JournalSubjectGroup>
<JournalSubject Type="Primary">Biomedicine</JournalSubject>
<JournalSubject Type="Secondary">Medical Microbiology </JournalSubject>
<JournalSubject Type="Secondary">Internal Medicine </JournalSubject>
<JournalSubject Type="Secondary">Infectious Diseases</JournalSubject>
<JournalSubject Type="Secondary">Immunology</JournalSubject>
</JournalSubjectGroup>
</JournalInfo>
<Volume OutputMedium="All">
<VolumeInfo TocLevels="0" VolumeType="Regular">
<VolumeIDStart>28</VolumeIDStart>
<VolumeIDEnd>28</VolumeIDEnd>
<VolumeIssueCount>6</VolumeIssueCount>
</VolumeInfo>
<Issue IssueType="Regular" OutputMedium="All">
<IssueInfo IssueType="Regular" TocLevels="0">
<IssueIDStart>1</IssueIDStart>
<IssueIDEnd>1</IssueIDEnd>
<IssueArticleCount>16</IssueArticleCount>
<IssueHistory>
<OnlineDate>
<Year>2008</Year>
<Month>1</Month>
<Day>9</Day>
</OnlineDate>
<PrintDate>
<Year>2008</Year>
<Month>1</Month>
<Day>9</Day>
</PrintDate>
<CoverDate>
<Year>2008</Year>
<Month>1</Month>
</CoverDate>
</IssueHistory>
<IssueCopyright>
<CopyrightHolderName>Springer Science+Business Media, LLC</CopyrightHolderName>
<CopyrightYear>2008</CopyrightYear>
</IssueCopyright>
</IssueInfo>
<Article ID="s10875-007-9131-x" OutputMedium="All">
<ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
<ArticleID>9131</ArticleID>
<ArticleDOI>10.1007/s10875-007-9131-x</ArticleDOI>
<ArticleSequenceNumber>8</ArticleSequenceNumber>
<ArticleTitle Language="En">Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals</ArticleTitle>
<ArticleFirstPage>50</ArticleFirstPage>
<ArticleLastPage>57</ArticleLastPage>
<ArticleHistory>
<RegistrationDate>
<Year>2007</Year>
<Month>8</Month>
<Day>21</Day>
</RegistrationDate>
<Received>
<Year>2007</Year>
<Month>6</Month>
<Day>16</Day>
</Received>
<Accepted>
<Year>2007</Year>
<Month>8</Month>
<Day>21</Day>
</Accepted>
<OnlineDate>
<Year>2007</Year>
<Month>9</Month>
<Day>18</Day>
</OnlineDate>
</ArticleHistory>
<ArticleCopyright>
<CopyrightHolderName>Springer Science+Business Media, LLC</CopyrightHolderName>
<CopyrightYear>2007</CopyrightYear>
</ArticleCopyright>
<ArticleGrants Type="Regular">
<MetadataGrant Grant="OpenAccess"></MetadataGrant>
<AbstractGrant Grant="OpenAccess"></AbstractGrant>
<BodyPDFGrant Grant="Restricted"></BodyPDFGrant>
<BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant>
<BibliographyGrant Grant="Restricted"></BibliographyGrant>
<ESMGrant Grant="Restricted"></ESMGrant>
</ArticleGrants>
</ArticleInfo>
<ArticleHeader>
<AuthorGroup>
<Author AffiliationIDS="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>Anurag</GivenName>
<FamilyName>Rathore</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>Animesh</GivenName>
<FamilyName>Chatterjee</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff2">
<AuthorName DisplayOrder="Western">
<GivenName>P.</GivenName>
<FamilyName>Sivarama</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff3">
<AuthorName DisplayOrder="Western">
<GivenName>Naohiko</GivenName>
<FamilyName>Yamamoto</FamilyName>
</AuthorName>
</Author>
<Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
<AuthorName DisplayOrder="Western">
<GivenName>Tapan</GivenName>
<GivenName>N.</GivenName>
<FamilyName>Dhole</FamilyName>
</AuthorName>
<Contact>
<Phone>+91-522-2668100</Phone>
<Fax>+91-522-2668100</Fax>
<Email>tndhole@hotmail.com</Email>
</Contact>
</Author>
<Affiliation ID="Aff1">
<OrgDivision>Department of Microbiology</OrgDivision>
<OrgName>Sanjay Gandhi Post Graduate Institute of Medical Sciences</OrgName>
<OrgAddress>
<Street>Raebarelli Road</Street>
<City>Lucknow</City>
<Postcode>226014</Postcode>
<Country Code="IN">India</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff2">
<OrgName>AIDS Counseling and Treatment Center</OrgName>
<OrgAddress>
<City>Belgaum</City>
<Country Code="IN">India</Country>
</OrgAddress>
</Affiliation>
<Affiliation ID="Aff3">
<OrgDivision>Department of International Health</OrgDivision>
<OrgName>Nagoya University School of Medicine</OrgName>
<OrgAddress>
<City>Nagoya</City>
<Country Code="JP">Japan</Country>
</OrgAddress>
</Affiliation>
</AuthorGroup>
<Abstract ID="Abs1" Language="En">
<Heading>Abstract</Heading>
<Para>Despite multiple sexual exposures to HIV-1 virus, some individuals remain HIV-1 seronegative. Although several genetic factors have been related to HIV-1 resistance, the homozygosity for a mutation in CCR5 gene (the 32-bp deletion, i.e., CCR5-Delta32 allele) is presently considered the most relevant one. The C-type lectins, DC-SIGN (present on dendritic cells and macrophages) and DC-SIGNR (present on endothelial cells in liver and lymph nodes) efficiently bind and transmit HIV-1 to susceptible cell
<Emphasis Type="Italic">in trans</Emphasis>
, thereby augmenting the infection. A potential association of the DC-SIGN and DC-SIGNR neck domain repeat polymorphism and risk of HIV-1 infection is currently under debate. To determine the influence of host genetic factors on HIV-1 resistance, we conducted genetic risk association study in HIV-1-exposed seronegative (
<Emphasis Type="Italic">n</Emphasis>
 = 47) individuals, HIV-1 seronegative (
<Emphasis Type="Italic">n</Emphasis>
 = 262) healthy control, and HIV-1-infected seropositive patients (
<Emphasis Type="Italic">n</Emphasis>
 = 168) for polymorphism in neck domain of DC-SIGN and DC-SIGNR genes. The DC-SIGN and DC-SIGNR genotypes were identified by polymerase chain reaction method in DNA extracted from peripheral blood and confirmed by sequencing. Fisher exact or
<Emphasis Type="Italic">χ</Emphasis>
<Superscript>2</Superscript>
test was used for static analysis. DC-SIGN genotype and allele distribution was fairly similar in HIV-1-exposed seronegative, HIV-1 seropositive, and HIV-1 seronegative control. There was no statistical significance in the differences in the distribution of DC-SIGN genotypes. A total of 13 genotypes were found in DC-SIGNR neck repeat region polymorphism. Among all the genotypes, only 5/5 homozygous showed significant reduced risk of HIV-1 infection in HIV-1-exposed seronegative individuals (
<Emphasis Type="Italic">p</Emphasis>
 = 0.009). A unique genotype 8/5 heterozygous was also found in HIV-1 seropositive individual, which is not reported elsewhere.</Para>
</Abstract>
<KeywordGroup Language="En">
<Heading>Keywords</Heading>
<Keyword>DC-SIGN</Keyword>
<Keyword>DC-SIGNR</Keyword>
<Keyword>HIV-1</Keyword>
<Keyword>tandem repeats</Keyword>
<Keyword>genetic association</Keyword>
<Keyword>gene polymorphism</Keyword>
</KeywordGroup>
</ArticleHeader>
<NoBody></NoBody>
</Article>
</Issue>
</Volume>
</Journal>
</Publisher>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals</title>
</titleInfo>
<name type="personal">
<namePart type="given">Anurag</namePart>
<namePart type="family">Rathore</namePart>
<affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Animesh</namePart>
<namePart type="family">Chatterjee</namePart>
<affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">P.</namePart>
<namePart type="family">Sivarama</namePart>
<affiliation>AIDS Counseling and Treatment Center, Belgaum, India</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Naohiko</namePart>
<namePart type="family">Yamamoto</namePart>
<affiliation>Department of International Health, Nagoya University School of Medicine, Nagoya, Japan</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal" displayLabel="corresp">
<namePart type="given">Tapan</namePart>
<namePart type="given">N.</namePart>
<namePart type="family">Dhole</namePart>
<affiliation>Department of Microbiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebarelli Road, 226014, Lucknow, India</affiliation>
<affiliation>E-mail: tndhole@hotmail.com</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="OriginalPaper" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo>
<publisher>Springer US; http://www.springer-ny.com</publisher>
<place>
<placeTerm type="text">Boston</placeTerm>
</place>
<dateCreated encoding="w3cdtf">2007-06-16</dateCreated>
<dateIssued encoding="w3cdtf">2008-01-01</dateIssued>
<copyrightDate encoding="w3cdtf">2007</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<abstract lang="en">Abstract: Despite multiple sexual exposures to HIV-1 virus, some individuals remain HIV-1 seronegative. Although several genetic factors have been related to HIV-1 resistance, the homozygosity for a mutation in CCR5 gene (the 32-bp deletion, i.e., CCR5-Delta32 allele) is presently considered the most relevant one. The C-type lectins, DC-SIGN (present on dendritic cells and macrophages) and DC-SIGNR (present on endothelial cells in liver and lymph nodes) efficiently bind and transmit HIV-1 to susceptible cell in trans, thereby augmenting the infection. A potential association of the DC-SIGN and DC-SIGNR neck domain repeat polymorphism and risk of HIV-1 infection is currently under debate. To determine the influence of host genetic factors on HIV-1 resistance, we conducted genetic risk association study in HIV-1-exposed seronegative (n = 47) individuals, HIV-1 seronegative (n = 262) healthy control, and HIV-1-infected seropositive patients (n = 168) for polymorphism in neck domain of DC-SIGN and DC-SIGNR genes. The DC-SIGN and DC-SIGNR genotypes were identified by polymerase chain reaction method in DNA extracted from peripheral blood and confirmed by sequencing. Fisher exact or χ 2 test was used for static analysis. DC-SIGN genotype and allele distribution was fairly similar in HIV-1-exposed seronegative, HIV-1 seropositive, and HIV-1 seronegative control. There was no statistical significance in the differences in the distribution of DC-SIGN genotypes. A total of 13 genotypes were found in DC-SIGNR neck repeat region polymorphism. Among all the genotypes, only 5/5 homozygous showed significant reduced risk of HIV-1 infection in HIV-1-exposed seronegative individuals (p = 0.009). A unique genotype 8/5 heterozygous was also found in HIV-1 seropositive individual, which is not reported elsewhere.</abstract>
<subject lang="en">
<genre>Keywords</genre>
<topic>DC-SIGN</topic>
<topic>DC-SIGNR</topic>
<topic>HIV-1</topic>
<topic>tandem repeats</topic>
<topic>genetic association</topic>
<topic>gene polymorphism</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Journal of Clinical Immunology</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>J Clin Immunol</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo>
<publisher>Springer</publisher>
<dateIssued encoding="w3cdtf">2008-01-09</dateIssued>
<copyrightDate encoding="w3cdtf">2008</copyrightDate>
</originInfo>
<subject>
<genre>Biomedicine</genre>
<topic>Medical Microbiology</topic>
<topic>Internal Medicine</topic>
<topic>Infectious Diseases</topic>
<topic>Immunology</topic>
</subject>
<identifier type="ISSN">0271-9142</identifier>
<identifier type="eISSN">1573-2592</identifier>
<identifier type="JournalID">10875</identifier>
<identifier type="IssueArticleCount">16</identifier>
<identifier type="VolumeIssueCount">6</identifier>
<part>
<date>2008</date>
<detail type="volume">
<number>28</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>1</number>
<caption>no.</caption>
</detail>
<extent unit="pages">
<start>50</start>
<end>57</end>
</extent>
</part>
<recordInfo>
<recordOrigin>Springer Science+Business Media, LLC, 2008</recordOrigin>
</recordInfo>
</relatedItem>
<identifier type="istex">9F928F739F1DB91A3396D803975A9B39B2F90D7A</identifier>
<identifier type="ark">ark:/67375/VQC-M6TN1N0C-H</identifier>
<identifier type="DOI">10.1007/s10875-007-9131-x</identifier>
<identifier type="ArticleID">9131</identifier>
<identifier type="ArticleID">s10875-007-9131-x</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Springer Science+Business Media, LLC, 2007</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</recordContentSource>
<recordOrigin>Springer Science+Business Media, LLC, 2007</recordOrigin>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/VQC-M6TN1N0C-H/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000585 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000585 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:9F928F739F1DB91A3396D803975A9B39B2F90D7A
   |texte=   Role of Homozygous DC-SIGNR 5/5 Tandem Repeat Polymorphism in HIV-1 Exposed Seronegative North Indian Individuals
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021